ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
bearish•Macroeconomics
•06 Nov 2023 18:46•Broker

Monthly Report: November 2023: Outlook: To Fall Further (With Some Rebounds), With the Support at 1,350/1,320 Points and the Resistance at 1,400/1,420 Points

KTX expects the SET Index to fall further (with some rebounds), with the support at 1,350/1,320 points and the resistance at 1,400 1,420 points,...

Logo
89 Views
Share
•24 Oct 2023 16:37•Broker

Strategy Update: Fear > Greed: No Fund Inflows, No Upside (Cash Remains King)

Given the current pervasive downside risks to the SET, along with the looming potential for it to touch a new low for the year (with this year's...

Logo
89 Views
Share
•20 Oct 2023 11:02•Broker

Today's Dominant Ideas

Technically, the SET Index is expected to weaken, with the resistance at 1,432/1,440 points (10-day EMA) and the support at 1,413/1,400...

Logo
91 Views
Share
bearish•Macroeconomics
•06 Oct 2023 18:36•Broker

Monthly Report: October 2023

KTX expects the SET Index to weaken, with the support at 1,445/1,425 points and the resistance at 1,505/1,535 points, This assessment is grounded...

Logo
91 Views
Share
bullish•Crude Oil
•04 Oct 2023 10:29•Broker

Today's Dominant Ideas

Technically, the SET Index is expected to weaken, with the support at 1,433/1,422 points and the resistance at 1,455/1,460 points. Keep a close...

Logo
86 Views
Share
x